June 2020
Volume 61, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2020
Fibroblast growth factor 21 protects against retinal degeneration in P23H mice
Author Affiliations & Notes
  • Zhongjie Fu
    Department of Ophthalmology, Children's Hosp Boston/Harvard Med Sch, Brookline, Massachusetts, United States
    Manton Center for Orphan Disease, Boston Children's Hospital, Massachusetts, United States
  • Bertan Cakir
    Department of Ophthalmology, Children's Hosp Boston/Harvard Med Sch, Brookline, Massachusetts, United States
  • Yohei Tomita
    Department of Ophthalmology, Children's Hosp Boston/Harvard Med Sch, Brookline, Massachusetts, United States
  • Cho Steve
    Department of Ophthalmology, Children's Hosp Boston/Harvard Med Sch, Brookline, Massachusetts, United States
  • William Britton
    Department of Ophthalmology, Children's Hosp Boston/Harvard Med Sch, Brookline, Massachusetts, United States
  • James D Akula
    Department of Ophthalmology, Children's Hosp Boston/Harvard Med Sch, Brookline, Massachusetts, United States
  • Saswata Talukdar
    Merck Research Laboratories, Massachusetts, United States
  • Ann Hellström
    Section for Ophthalmology, Department of Clinical Neuroscience and rehabilitation, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden
  • Lois E H Smith
    Department of Ophthalmology, Children's Hosp Boston/Harvard Med Sch, Brookline, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Zhongjie Fu, Boston Children's Hospital (P); Bertan Cakir, None; Yohei Tomita, None; Cho Steve, None; William Britton, None; James Akula, None; Saswata Talukdar, None; Ann Hellström, None; Lois Smith, Boston Children's Hospital (P)
  • Footnotes
    Support  BCH OFD/BTREC/CTREC Faculty Career Development Grant, Manton Center for Orphan Disease Research, Little Giraffe Foundation,
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 3218. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Zhongjie Fu, Bertan Cakir, Yohei Tomita, Cho Steve, William Britton, James D Akula, Saswata Talukdar, Ann Hellström, Lois E H Smith; Fibroblast growth factor 21 protects against retinal degeneration in P23H mice. Invest. Ophthalmol. Vis. Sci. 2020;61(7):3218.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Retinitis pigmentosa (RP) is a general term for retinal degenerations affecting about 1 in 4000 people in the U.S. It is typically diagnosed in adolescence. Most people with RP are legally blind by age 40. Cellular metabolic gene expression changes indicating starvation coincide with the onset of cone death, suggesting that cones suffer from a metabolic shortage after loss of factors such as rod-derived cone viability factor, which promotes glucose uptake in cones. We investigated if fibroblast growth factor 21 (FGF21), a strong metabolic modulator, protects against retinal degeneration in RP.

Methods : The P23H mutation of rhodopsin (amino acid substitution of histidine for phenylalanine at position 23) is the most common cause (15-18% of all adRP cases in US). In a mouse model of heterozygous P23H mutant mice, long-acting FGF21 PF-05231023 10mg/kg (half-life in mouse serum is 28 hours) or vehicle were intraperitoneally injected twice a week when cone responses start to decrease. After 1-to-2-months of treatment, we examined retinal rod and cone function with electroretinography (ERG, n=22-30), retinal thickness with optical coherence tomography (OCT, n=8-10), and retinal structure with immunohistochemistry (IHC, n=4-5). Rod, cone, Müller cell and other cell responses to FGF21 administration was investigated with single-cell transcriptomic analysis (control: 18,000 cells; FGF21: 12,000 cells). The pathways were investigated using Gene Set Enrichment Analysis (GSEA) and Gene ontology (GO) analysis. The results were validated with immunohistochemistry. Both male and female mice were used. t test, or ANOVA was used for statistical analysis.

Results : In P23H mutant mice, FGF21 protected against photoreceptor degeneration. Retinal function was examined at postnatal week (PW) 4, 7, and 10. FGF21 protected against rod loss at PW7 (a wave amplitude: P<0.001; b wave amplitude: P<0.05) and cone degeneration at PW10 (b wave amplitude: P<0.001; b wave sensitivity: P<0.05) in P23H mutant mice. FGF21 did not change retinal thickness. FGF21 activates serum response factor (P<0.001, FDR<0.001) and neurogenesis potential (P<0.001) in Müller cells. Mild impacts of FGF21 on rod or cone metabolism were observed.

Conclusions : FGF21 protects against photoreceptor degeneration possibly through modulating Müller glial cell neurogenesis potential in retinal degeneration.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×